We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KLAC:NASDAQKLA Corporation Analysis

Data as of 2026-05-28 - not real-time

$1,956.56

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KLA Corporation is riding a wave of bullish sentiment, highlighted by a recent ten‑for‑one forward stock split approval and a 6.6% price jump after strong AI‑driven chip demand signals. The stock sits at $1,956.56, well above its 20‑day SMA of $1,827.86 and comfortably above the 50‑day SMA of $1,724, confirming a bullish trend reinforced by a bullish MACD histogram of +10.34. However, the price is still below the 52‑week high of $2,060.08 and faces a technical resistance around $2,060, while the nearest support lies near $1,646.
Fundamentally, KLAC delivers exceptional profitability with a gross margin of 61% and operating margin of 41%, alongside a ROE near 95%, but its valuation appears stretched – a trailing P/E of 55.5 versus an industry average of 41, and a DCF fair value of $462 versus the current market price. The dividend yield is modest at 0.47% with a low payout ratio of 21.5%, suggesting sustainability despite the high valuation. Investors should weigh the strong growth narrative against the elevated price and volatility (≈50% 30‑day) before deciding.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical resistance with decreasing volume trend
  • Bullish technical indicators but stretched valuation
  • Recent stock split announcement may cause short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • AI‑driven semiconductor demand supporting revenue growth
  • Strong profit margins and cash generation
  • Potential inflow from split‑induced retail interest

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained high ROE and cash flow underpin business resilience
  • Valuation premium may compress over multiple years
  • Secular exposure to advanced packaging and AI chip cycles

Key Metrics & Analysis

Financial Health

Revenue Growth11.50%
Profit Margin35.66%
P/E Ratio55.5
ROE94.98%
ROA21.28%
Debt/Equity105.40
P/B Ratio43.9
Op. Cash Flow$4.4B
Free Cash Flow$2.9B
Industry P/E41.0

Technical Analysis

TrendBullish
RSI61.0
Support$1,646.00
Resistance$2,060.08
MA 20$1,827.86
MA 50$1,724.01
MA 200$1,344.28
MACDBullish
VolumeDecreasing
Fear & Greed Index93.02

Valuation

Fair Value$462.42
Target Price$1,855.14
Upside/Downside-5.18%
GradeOvervalued
TypeGrowth
Dividend Yield0.47%

Risk Assessment

Beta2.32
Volatility49.84%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.